Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $251000.0.

  • Rapid Micro Biosystems' Change in Account Payables rose 6733.33% to $251000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 23347.5%. This contributed to the annual value of $562000.0 for FY2024, which is 11626.63% up from last year.
  • Rapid Micro Biosystems' Change in Account Payables amounted to $251000.0 in Q3 2025, which was up 6733.33% from $700000.0 recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Change in Account Payables ranged from a high of $1.9 million in Q3 2023 and a low of -$4.1 million during Q1 2023
  • In the last 5 years, Rapid Micro Biosystems' Change in Account Payables had a median value of $100000.0 in 2025 and averaged -$46421.1.
  • In the last 5 years, Rapid Micro Biosystems' Change in Account Payables tumbled by 103750.0% in 2022 and then surged by 121948.05% in 2024.
  • Rapid Micro Biosystems' Change in Account Payables (Quarter) stood at $1.7 million in 2021, then grew by 3.96% to $1.8 million in 2022, then plummeted by 173.79% to -$1.3 million in 2023, then soared by 115.79% to $205000.0 in 2024, then increased by 22.44% to $251000.0 in 2025.
  • Its last three reported values are $251000.0 in Q3 2025, $700000.0 for Q2 2025, and $100000.0 during Q1 2025.